Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
10,554,208
-
Shares change
-
+3,931,635
-
Total reported value, excl. options
-
$167,568,706
-
Value change
-
+$63,117,936
-
Number of buys
-
42
-
Number of sells
-
-13
-
Price
-
$15.88
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2019
66 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2019.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,554,208 shares
of 43,411,663 outstanding shares and own 24.3% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (1,870,000 shares), Nantahala Capital Management, LLC (1,404,941 shares), BlackRock Inc. (1,387,669 shares), Slate Path Capital LP (890,000 shares), VANGUARD GROUP INC (889,716 shares), MANGROVE PARTNERS (601,398 shares), STATE STREET CORP (333,701 shares), 683 Capital Management, LLC (320,000 shares), Corriente Advisors, LLC (285,000 shares), and Crestwood Advisors Group LLC (270,000 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.